Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

NCT05856084 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

924

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Low dose Recombinant Herpes Zoster Vaccine (CHO cells)
BIOLOGICAL: High dose Recombinant Herpes Zoster Vaccine (CHO cells)
BIOLOGICAL: Positive control
BIOLOGICAL: Placebo

Sponsor

MAXVAX Biotechnology Limited Liability Company

Collaborators

[object Object]